Drug Shortage Report for CYTOVENE
Report ID | 184528 |
Drug Identification Number | 02162695 |
Brand name | CYTOVENE |
Common or Proper name | ganciclovir for injection |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | GANCICLOVIR |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mg/vial |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-14 |
Estimated end date | 2024-03-31 |
Actual end date | 2024-03-13 |
Shortage status | Resolved |
Updated date | 2024-03-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.